Auna S.A. (NYSE:AUNA) Receives $7.30 Average PT from Brokerages

Shares of Auna S.A. (NYSE:AUNA) have been assigned a consensus rating of “Moderate Buy” from the five analysts that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating, one has issued a buy rating and two have assigned a strong buy rating to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $7.30.

A number of equities research analysts have recently issued reports on the company. Jefferies Financial Group initiated coverage on Auna in a research report on Friday, January 16th. They set a “buy” rating and a $9.00 target price on the stock. Wall Street Zen upgraded Auna from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 28th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $6.00 price target (down from $13.50) on shares of Auna in a research note on Tuesday, November 18th. Zacks Research upgraded Auna from a “strong sell” rating to a “strong-buy” rating in a report on Monday, February 9th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Auna in a research note on Monday, December 29th.

Auna Trading Down 4.4%

Auna stock opened at $4.97 on Friday. The firm has a market cap of $367.83 million, a price-to-earnings ratio of 13.81 and a beta of 2.09. Auna has a 1 year low of $4.46 and a 1 year high of $7.57. The firm’s 50 day moving average price is $4.96 and its two-hundred day moving average price is $5.43. The company has a debt-to-equity ratio of 1.87, a quick ratio of 0.82 and a current ratio of 1.11.

Auna (NYSE:AUNA) last announced its quarterly earnings data on Tuesday, March 10th. The company reported $0.53 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.42. The company had revenue of $336.67 million during the quarter, compared to the consensus estimate of $1.08 billion. Auna had a return on equity of 19.23% and a net margin of 2.13%. On average, research analysts predict that Auna will post 0.5 EPS for the current fiscal year.

Institutional Investors Weigh In On Auna

Hedge funds have recently made changes to their positions in the company. Goldman Sachs Group Inc. purchased a new position in Auna during the 1st quarter worth approximately $219,000. Fiera Capital Corp raised its stake in Auna by 2.7% during the 2nd quarter. Fiera Capital Corp now owns 1,558,358 shares of the company’s stock valued at $9,662,000 after purchasing an additional 40,673 shares during the period. Hohimer Wealth Management LLC purchased a new stake in shares of Auna in the second quarter valued at $264,000. Sage Investment Counsel LLC purchased a new stake in shares of Auna in the third quarter valued at $67,000. Finally, Virtu Financial LLC acquired a new stake in shares of Auna in the third quarter worth $75,000.

Key Auna News

Here are the key news stories impacting Auna this week:

• Positive Sentiment: Q4 EPS beat and operating resilience — Auna reported $0.53 EPS vs. a $0.11 consensus, with a 19.3% ROE that signals profitable operations in core segments. Press Release
• Positive Sentiment: 2026 growth targets aim to re-rate the story — Management is targeting roughly 12% revenue and EBITDA growth for 2026, giving investors a clear multi‑year growth objective if execution holds. Article
• Positive Sentiment: Mexico turnaround progressing — Q4 showed stabilization in Mexico, a sequential 35% jump in oncology revenue, and new payer deals (including ISSSTELEON) that could drive 2026 growth and margin recovery. Article
• Neutral Sentiment: Analyst sentiment generally constructive — Auna was added to Zacks’ top value list (Rank #1) and carries a consensus “Moderate Buy” from analysts, indicating continued analyst support but not unanimous bullishness. Zacks Consensus Note
• Neutral Sentiment: Management commentary available — The full earnings call transcript and slide deck provide detail on cost actions and growth priorities; useful for investors deciding if guidance is credible. Transcript
• Negative Sentiment: Revenue confusion / perceived shortfall — While EPS beat, reported Q4 revenue ($336.7M) was cited well below certain aggregates (~$1.08B) in some summaries, which likely spurred investor caution and contributed to the pullback. Earnings Summary
• Negative Sentiment: Liquidity and leverage remain watch‑points — Auna’s current ratio (~0.9), quick ratio (~0.82) and debt/equity (~1.63) raise short‑term liquidity and leverage concerns; together with a beta >2, these factors increase downside risk if execution slips. Profile

Auna Company Profile

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.